November 13, 2024 09:15 AM EST
Deals
Manufacturing

Ot­su­ka and ICU Med­ical forge IV man­u­fac­tur­ing net­work to sup­ply the US

Anna Brown

News Reporter

Ot­su­ka Phar­ma­ceu­ti­cal Fac­to­ry is pay­ing $200 mil­lion to the med­ical equip­ment com­pa­ny ICU Med­ical for an al­liance to sup­ply IV prod­ucts to the US. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Car­olyn Bertozzi’s lat­est biotech de­buts with $30M seed round and a sug­ary spin on im­munother­a­py

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times